Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023
Archives of Virology · 2026
DOI: 10.1007/s00705-025-06453-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2026. Verfasst von Yi Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road No. 169, Wuchang District, Wuhan, 430071, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Genome, Viral. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Fund of Hubei Province, Key Research and Development Program of Hubei Province, Hubei Provincial Leading Public Health Talents Project.
Abstract (Originalsprache)
The COVID-19 pandemic caused by SARS-CoV-2 has had a significant impact on global social and economic activities. The continuous emergence of new SARS-CoV-2 variants has made the global pandemic of COVID-19 difficult to predict. Therefore, it is of great significance to closely monitor the SARS-CoV-2 epidemic and understand the evolution and transmission characteristics of SARS-CoV-2. In this study, we examined 36 cases of SARS-CoV-2 infection in Wuhan in June 2023. Genomic surveillance revealed that this outbreak was caused by Omicron XBB variants, among which FY.3 and its descendants FY.3.1 and FY.3.2 dominated, and this trend was consistent with the prevalence of SARS-CoV-2 nationwide in June and July. Analysis of sequence variations within hosts and between populations suggested that the S and ORF8 genes had undergone positive selection, possibly due to their important role in host adaptation, suggesting that some of these variations might be harmful mutations that reduce vaccine effectiveness. These findings may provide insights that will aid in predicting the evolutionary direction of SARS-CoV-2 in terms of variant competition, informing the design of next-generation multivalent vaccines and therapeutic strategies targeting conserved or rapidly evolving regions such as the S and ORF8 genes and supporting the evaluation and adjustment of surveillance, prevention, and control strategies in the Wuhan region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road No. 169, Wuchang District, Wuhan, 430071, China.
- Wuhan Primbio Medical Laboratory, Wuhan, 430064, China.
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, C…
- Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Donghu Road No. 169, Wuchang District, Wuhan, 430071, China. liyirong838@163.com.
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Donghu Road No. 169, Wuchang District, Wuhan, 430071, China. lizhiqiang@whu.edu.cn.
Förderung
- Natural Science Fund of Hubei Province
- Key Research and Development Program of Hubei Province
- Hubei Provincial Leading Public Health Talents Project
- National Natural Science Foundation of China
Zitieren
APA
Yan, Y., Pan, Z., Mao, L., Niu, P., Lu, F., Li, Y., & Li, Z. (2026). Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023. Archives of Virology. https://doi.org/10.1007/s00705-025-06453-9
Vancouver
Yan Y, Pan Z, Mao L, Niu P, Lu F, Li Y, et al. Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023. Archives of Virology. 2026. doi:10.1007/s00705-025-06453-9
BibTeX
@article{Yan2026,
author = {Yan, Yi and Pan, Zhiyong and Mao, Liangwei and Niu, Peihua and Lu, Fei and Li, Yirong and Li, Zhiqiang},
title = {Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023},
journal = {Archives of Virology},
year = {2026},
doi = {10.1007/s00705-025-06453-9}
}
EUVIMED